Pulse Biosciences Announces First Successful Procedures in PRECISE Benign Thyroid Nodule (BTN) Study
“Successful procedures for the first enrolled patients in our PRECISE-BTN clinical study for the treatment of benign thyroid nodules (BTNs) marks a significant milestone not only for Pulse Biosciences ...
Thyroid nodules commonly develop in humans and are variable in size, shape and location. Most of these growths are not cancer but may create symptoms of discomfort over time depending on the size, and ...
As a seasoned nurse with years of experience in high-acuity settings like the Burn ICU at Vanderbilt, Hillary Sexton is no stranger to high standards in healthcare. So when she was diagnosed with a ...
Thyroid nodules commonly develop in humans and are variable in size, shape and location. Most of these growths are not cancer but may create symptoms of discomfort over time depending on the size, and ...
Microwave ablation was associated with similar progression-free survival rates to surgery (five year: 77.2% vs. 83.1%) but with fewer complications and a greater potential for preserving thyroid ...
Sarasota Memorial Hospital is part of a study on a new ablation treatment for non-cancerous thyroid nodules. The study uses Nanosecond Pulsed Field Ablation technology to destroy abnormal tissue while ...
JOHNSTOWN, Pa. (WTAJ) — Up to 60% of people will develop thyroid nodules by the age of 60, and while most don’t cause any symptoms, for some, they can make it difficult to swallow, breathe and speak.
Looking at Fariha Dhanani, there are no signs that her thyroid has been completely removed. While most patients who opt for this type of surgery have a tell-tale scar across the neck, Dhanani opted ...
Routinely removing lymph nodes in the neck of patients with thyroid cancer may help prevent the disease from recurring, according to a new study (Surgery, December 2011, Vol. 150:6, pp. 1048-1057).
Pulse Biosciences Announces First Successful Procedures in PRECISE Benign Thyroid Nodule (BTN) Study
HAYWARD, Calif.--(BUSINESS WIRE)-- Pulse Biosciences, Inc. (PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) technology, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results